Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sclerosing cholangitis.

Jayant A Talwalkar1, Keith D Lindor

  • 1Mayo Medical School and Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

Current Opinion in Gastroenterology
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Betaine in the treatment of steatotic liver disease-Historical fad or a timeless treasure worth reviving?

Hepatology (Baltimore, Md.)·2025
Same author

Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid.

JHEP reports : innovation in hepatology·2023
Same author

Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival.

Liver international : official journal of the International Association for the Study of the Liver·2023
Same author

Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis.

Hepatology (Baltimore, Md.)·2023
Same author

Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis.

The American journal of gastroenterology·2023
Same author

Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe.

European journal of gastroenterology & hepatology·2022
Same journal

Neuroendocrine tumors of the stomach and duodenum: evolving classification, endoscopic management, and surveillance.

Current opinion in gastroenterology·2026
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
See all related articles

Primary sclerosing cholangitis (PSC) in children may resemble autoimmune hepatitis. Research explores genetic factors, diagnostic tools, and treatments like ursodeoxycholic acid for PSC, with liver transplantation as a last resort.

Area of Science:

  • Hepatology
  • Immunogenetics
  • Gastroenterology

Background:

  • Primary sclerosing cholangitis (PSC) in children can present similarly to autoimmune hepatitis, especially when inflammatory bowel disease is absent.
  • Genetic factors, including human leukocyte antigens (HLA) and cytokine polymorphisms, play a role in disease susceptibility in adults.
  • The role of primary alpha-hemolytic streptococci infection in PSC etiology is not supported by current evidence.

Purpose of the Study:

  • To review current understanding of PSC in children and adults.
  • To evaluate diagnostic modalities and therapeutic interventions for PSC.
  • To discuss the implications of genetic factors and disease recurrence after liver transplantation.

Main Methods:

  • Literature review and synthesis of existing research on primary sclerosing cholangitis.

Related Experiment Videos

  • Analysis of genetic associations (HLA, cytokine polymorphisms) and etiological factors.
  • Evaluation of diagnostic imaging techniques (SPECT, PET, DNA cytometry) and therapeutic outcomes (ursodeoxycholic acid, endoscopic therapy, liver transplantation).

    • Main Results:

    • Genetic factors like HLA alleles and cytokine polymorphisms are linked to PSC susceptibility.
    • Advanced imaging like PET and DNA cytometry show promise for detecting cholangiocarcinoma.
    • High-dose ursodeoxycholic acid may halt disease progression, while endoscopic therapy's impact is unclear.

    Conclusions:

    • PSC in children can mimic other liver conditions, necessitating careful diagnosis.
    • Genetic predisposition is significant in PSC, while certain infections are unlikely causes.
    • Further research is needed on diagnostic tools, chemoprevention, and the long-term effects of treatments, including liver transplant outcomes.